The Next Generation in Immuno-Oncology

OUR TECHNOLOGY

Meditope Biosciences is revolutionizing the use of monoclonal antibodies. Our proprietary SnAP technology leverages a naturally occurring space in an antibody and carves it into a binding site.

OUR TEAM

Drawn by a passion for the SnAP technology and all the innovative potential that it represents, the Meditope Biosciences' team represents an impressive and  remarkable blend of breadth and depth of experience.